کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5982968 1577093 2014 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Aspirin Therapy in Primary Cardiovascular Disease Prevention: A Position Paper of the European Society of Cardiology Working Group on Thrombosis
ترجمه فارسی عنوان
درمان آسپرین در پیشگیری از بیماری های قلبی عروقی اولیه: مقاله ای از کار گروهی از انجمن کاردیولوژی اروپا در مورد ترومبوز
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی

Although the use of oral anticoagulants (vitamin K antagonists) has been abandoned in primary cardiovascular prevention due to lack of a favorable benefit-to-risk ratio, the indications for aspirin use in this setting continue to be a source of major debate, with major international guidelines providing conflicting recommendations. Here, we review the evidence in favor and against aspirin therapy in primary prevention based on the evidence accumulated so far, including recent data linking aspirin with cancer protection. While awaiting the results of several ongoing studies, we argue for a pragmatic approach to using low-dose aspirin in primary cardiovascular prevention and suggest its use in patients at high cardiovascular risk, defined as ≥2 major cardiovascular events (death, myocardial infarction, or stroke) projected per 100 person-years, who are not at increased risk of bleeding.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of the American College of Cardiology - Volume 64, Issue 3, 22 July 2014, Pages 319-327
نویسندگان
, , , , , , , , , , ,